This article is currently undergoing investigation.
Research Paper Volume 12, Issue 24 pp 25767—25777
Zinc oxide nanoparticles (ZnO NPs) combined with cisplatin and gemcitabine inhibits tumor activity of NSCLC cells
Figure 1. Physicochemical property of ZnO NPs(Cp/Gem). (A) The morphologies of ZnO NPs(Cp/Gem) by transmission electron microscopy. (B) Size distributions of ZnO NPs(Cp/Gem) determined by dynamic light scattering at 0 and 48 h.